Wednesday, October 14, 2020

US drugmaker pauses Covid-19 trial over safety concerns

Eli Lilly suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalised patients over an unspecified incident.

from KT Mobile https://ift.tt/3jSd9Jc
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)